Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA).

PubWeight™: 0.82‹?›

🔗 View Article (PMID 1648582)

Published in J Affect Disord on March 01, 1991

Authors

G B Baker1, J T Wong, J M Yeung, R T Coutts

Author Affiliations

1: PMHAC Research Unit, University of Alberta, Edmonton, Canada.

Articles citing this

Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91

Metabolism of monoamine oxidase inhibitors. Cell Mol Neurobiol (1999) 0.87

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? J Psychiatry Neurosci (2007) 0.80

Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol (2001) 0.79

Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration. Psychopharmacology (Berl) (2016) 0.77

Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77

Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. J Psychiatry Neurosci (2002) 0.75

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. Int J Neuropsychopharmacol (2015) 0.75

Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine. J Neural Transm (Vienna) (2013) 0.75

Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology. Front Pharmacol (2016) 0.75

Articles by these authors

Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol (1992) 3.13

A co-evolution theory of the genetic code. Proc Natl Acad Sci U S A (1975) 2.79

Evaluation of rate constants for enzyme-catalysed reactions by the jackknife technique. Application to liver alcohol dehydrogenase. Biochem J (1978) 1.85

An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80

Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J Immunol (1987) 1.64

An improved procedure for extraction and analysis of cellular nucleotides. Anal Biochem (1970) 1.38

The evolution of a universal genetic code. Proc Natl Acad Sci U S A (1976) 1.32

Kinetic mechanism for the major isoenzyme of horse liver alcohol dehydrogenase. Can J Biochem (1972) 1.32

Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis (1995) 1.30

The effect of lipid environment and retinoids on the ATPase activity of ABCR, the photoreceptor ABC transporter responsible for Stargardt macular dystrophy. J Biol Chem (2000) 1.28

Evolutionary relationship between Halobacterium cutirubrum and eukaryotes determined by use of aminoacyl-tRNA synthetases as phylogenetic probes. Can J Biochem (1980) 1.23

Interactive editing of biomedical data. Comput Programs Biomed (1976) 1.20

Evaluation of antigen-specific responses using in vitro enriched T cells. J Immunol Methods (2003) 1.19

Relationship of the MS nucleotides to the regulation of ribonucleic acid synthesis in Escherichia coli. J Biol Chem (1970) 1.16

Membership mutation of the genetic code: loss of fitness by tryptophan. Proc Natl Acad Sci U S A (1983) 1.16

Surface plasmon resonance-based immunoassays. Methods (2000) 1.13

Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry. J Pharm Pharmacol (1973) 1.10

Identity elements of tRNA(Trp). Identification and evolutionary conservation. J Biol Chem (1993) 1.09

Suppression of fluorescence of tryptophan residues in proteins by replacement with 4-fluorotryptophan. Biochem J (1988) 1.08

The modulation of choline phosphoglyceride metabolism in human colon cancer. Mol Cell Biochem (1996) 1.08

Cloning and nucleotide sequence of the structural gene coding for Bacillus subtilis tryptophanyl-tRNA synthetase. Gene (1988) 1.07

Role of minimization of chemical distances between amino acids in the evolution of the genetic code. Proc Natl Acad Sci U S A (1980) 1.06

Inadequacy of prebiotic synthesis as origin of proteinous amino acids. J Mol Evol (1979) 1.05

Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01

Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res (1997) 0.98

Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97

Synthesis of N-[[(substituted-phenyl)carbonyl]amino]-1,2,3,6-tetrahydropyridines with analgesic and hyperglycemic activity. J Med Chem (1982) 0.97

The evidence for G-protein-coupled receptors and heterotrimeric G proteins in protozoa and ancestral metazoa. Biol Signals Recept (1998) 0.97

Purification and properties of an N-formylmethionyl-tRNA hydrolase. Eur J Biochem (1976) 0.96

CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res Hum Retroviruses (1993) 0.96

Inhibitor-induced shift-downs in Escherichia coli. J Bacteriol (1969) 0.95

Natural selection versus primitive gene structure as determinant of codon usage. Eur J Biochem (1986) 0.94

Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94

Immunoassay of fumonisins by a surface plasmon resonance biosensor. Anal Biochem (1998) 0.94

Soluble dextran-hemoglobin complex as a potential blood substitute. Proc Natl Acad Sci U S A (1976) 0.93

Interpretation of nonhyperbolic behavior in enzymic systems. II. Quantitative characteristics of rate and binding functions. Can J Biochem (1971) 0.93

Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92

Sequences of halobacterial tRNAs and the paucity of U in the first position of their anticodons. Nucleic Acids Res (1983) 0.92

Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91

In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc Natl Acad Sci U S A (1997) 0.90

Purification of isoenzyme and coenzymes for kinetic study of horse liver alcohol dehydrogenase. Can J Biochem (1972) 0.89

Variation of ribosomal proteins with bacterial growth rate. J Bacteriol (1975) 0.89

Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev (1998) 0.88

Regulation of amino acid-specific transfer RNA's in Escherichia coli. Biochim Biophys Acta (1969) 0.88

3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. J Med Chem (2001) 0.87

T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clin Exp Immunol (1992) 0.87

Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res (1988) 0.87

Sequence data for two large-subunit rRNA genes from an Asian strain of Alexandrium catenella. Appl Environ Microbiol (1996) 0.87

A thermal-variation method for analysing the rate constants of the Michaelis--Menten mechanism. Biochem J (1982) 0.86

Comparison of chemical components and antioxidants capacity of different Echinacea species. J Pharm Pharmacol (2001) 0.86

Topological analysis of enzymic mechanisms. Acta Biol Med Ger (1973) 0.86

Left ventricular diastolic function during normal pregnancy: assessment by spectral tissue Doppler imaging. Ultrasound Obstet Gynecol (2006) 0.86

Tryptophanyl-tRNA synthetase from Bacillus subtilis. Characterization and role of hydrophobicity in substrate recognition. J Biol Chem (1989) 0.85

Nucleotide changes and the regulation of ribonucleic acid accumulation during growth rate shifts in Escherichia coli. J Biol Chem (1972) 0.85

Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method. J Clin Microbiol (2000) 0.85

A concerted tryptophanyl-adenylate-dependent conformational change in Bacillus subtilis tryptophanyl-tRNA synthetase revealed by the fluorescence of Trp92. J Mol Biol (1996) 0.85

Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr (1992) 0.85

Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (2000) 0.84

Purification of hyperexpressed Bacillus subtilis tRNA(Trp) cloned in Escherichia coli. J Chromatogr (1993) 0.84

Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther (1991) 0.84

Calcium ion dependency and the role of inositol phosphates in melatonin-induced encystment of dinoflagellates. J Cell Sci (1997) 0.84

Synthesis of soluble dextran-hemoglobin complexes of different molecular sizes. Can J Biochem (1977) 0.84

Vitamin E potentiates arachidonate release and phospholipase A2 activity in rat heart myoblastic cells. Biochem J (1996) 0.84

Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol (2000) 0.83

Regulation of ribonucleic acid accumulation in vivo by nucleoside triphosphates. J Biol Chem (1972) 0.83

Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry (1991) 0.83

Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83

Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. J Chromatogr (1986) 0.83

Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics (1987) 0.82

Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82

Effect of deoxynivalenol on neurotransmitters in discrete regions of swine brain. Arch Environ Contam Toxicol (1992) 0.82

Site of energy coupling in the carrier mechanism for beta-galactoside transport. Biochim Biophys Acta (1971) 0.82

Interactions of iprindole with fenfluramine metabolism in rat brain and liver. J Psychiatry Neurosci (1991) 0.82

Isolation and characterization of the Bacillus subtilis tryptophanyl-tRNA synthetase gene (trpS) conferring 5-fluorotryptophan resistance and temperature sensitivity. Biochim Biophys Acta (1996) 0.82

Blood replacement in dogs by dextran-hemoglobin. Can J Biochem (1978) 0.82

The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) (1996) 0.82

Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells. J Lipid Res (1999) 0.81

Separation of tRNA by high-performance liquid chromatography at ambient temperature. J Chromatogr (1986) 0.81

The spindle checkpoint in the dinoflagellate Crypthecodinium cohnii. Exp Cell Res (2000) 0.81

Interpretation of nonhyperbolic behavior in enzymic systems. I. Differentiation of model mechanisms. Can J Biochem (1971) 0.81

Prenatal cocaine exposure selectively reduces mesocortical dopamine release. J Pharmacol Exp Ther (1995) 0.81

Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor. J Pineal Res (1999) 0.81

Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Dev Pharmacol Ther (1988) 0.80

Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol Sin (2000) 0.80

Evaluation of enzyme-linked immunosorbent assay for analysis of beer for fumonisins. Food Addit Contam (1997) 0.80

Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man. Res Commun Chem Pathol Pharmacol (1977) 0.80

Metabolism in vitro of N-methylamphetamine with rat liver homogenates. Biochem Pharmacol (1977) 0.80

NMR studies of Bacillus subtilis tRNA(Trp) hyperexpressed in Escherichia coli. Assignment of imino proton signals and determination of thermal stability. J Biol Chem (2000) 0.80

Synthesis and assembly of ribosomal proteins at the onset of pyrimidine starvation. Biochem Biophys Res Commun (1970) 0.79

In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Drug Metab Dispos (1976) 0.79

Recognition of early and late biosynthetic classes ribosomal proteins in Escherichia coli. Can J Biochem (1971) 0.79

Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin. Life Sci (2000) 0.79

High-level expression of Bacillus subtilis tryptophanyl-tRNA synthetase in Escherichia coli. Biochem Cell Biol (1990) 0.79

Fungal metabolism of (-)-deprenyl and pargyline. Life Sci (1981) 0.79

In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates. J Pharm Pharmacol (1976) 0.79

Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol (1986) 0.79

Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79

Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. J Chromatogr B Biomed Sci Appl (1997) 0.79

Synthesis of N-(carbonylamino)-1,2,3,6-tetrahydropyridines with analgesic, antiinflammatory, and hyperglycemic activity. J Med Chem (1982) 0.79